期刊文献+

肿瘤多药耐药和侵袭转移关系的研究 被引量:2

Relationship between cancer metastasis and drug resistance
原文传递
导出
摘要 肿瘤的侵袭转移和多药耐药是肿瘤治疗的两大难点,过去对两者的研究都是独立进行的。近年来的研究发现多药耐药和侵袭转移之间可能存在某种关联,化疗是否会促进肿瘤的侵袭转移以及多药耐药和侵袭转移之间是否密切相关均需要进一步的研究。探讨两者可能存在的临床相关性及深入了解两者之间的内在关系无疑对肿瘤治疗具有重要的指导意义。 Cancer metastasis and drug resistance have puzzled doctors for many years. Studies in these two fields in the past generally proceed separately. Recent studies find there may be a correlation between drug resistance and cancer invasion and metastasis. Can chemtherapy promote tumor invasion and metastasis,is there a close correlation between drug resistance and tumor invasion and metastasis? They both need further studies. A better understanding of any relationship between drug resistance and cancer invasion can lead to more effective cancer treatment.
出处 《国际肿瘤学杂志》 CAS 2006年第9期665-667,共3页 Journal of International Oncology
基金 上海市科委基金资助项目(054001)
关键词 抗药性 肿瘤 抗药性 多药 肿瘤侵润 肿瘤转移 Drug resistance, neoplasm Drug resistance, multiple Neoplasm invasiveness Neoplasm metastasis
  • 相关文献

参考文献21

  • 1Ambudkar SV, Lelong IH, Zhan J,et al. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci USA, 2002,89(18) :8472-8476.
  • 2Cole SP, Bhardwa jG, Gerlach JH, et al. Overexpression of a transporter gene in a muhidrug-resistant human lung cancer cell line. Science,1992, 258( 5088 ) : 1650-1654.
  • 3Poupon R. Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group. J Hepatol,2003, 30(3 ) :408-412.
  • 4Hanania N, Boyano MD, Mangln C,et al. Oncogene and MDR1 gene expression in rat rhabdomyosarcoma sublines of different metastatic potential. Anticancer Res, 2001, 11 ( 1 ) :473-480.
  • 5McMillan TJ, Rao J, Hart IR, et al.Interferon-induced alterations in metastatic capacity, class-1 antigen expression and natural killer cell sensitivity of melanoma cells. Int J Cancer, 1987,40( 5 ) :659-663.
  • 6Osmak M, Vrhovec I, Skrk J. Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1. J Neurooncol, 1999, 42(2) :95-102.
  • 7De Larco JE, Wuertz BR, Manivel JC,et al. Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents. Cancer Res, 2001,61 (7) :2857-2861.
  • 8Kamura T. Alteration of metastatic potential of ovarian cancer in clinical course . Nippon Sanka Fujinka Gakkai Zasshi, 1996,48(8) :607-617.
  • 9Slotman G J, Mohit T, Raina S, et al. The incidence of metastases after multimodal therapy for cancer of the head and neck. Cancer, 1984,54(9) :2009-2014.
  • 10Weinstein RS, Jakate SM, Dominguez JM, et al. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res, 1991,51 (10) :2720-2726.

同被引文献11

  • 1Jordan P,Carmo-Fonseca M.Molecular mechanisms involved in cisplatin cytotoxicity [J].Cell Mol Life Sci,2000,57(8-9):1229-1235.
  • 2Ullah MF.Cancer multidrug resistance(MDR):A major impediment to effective chemotherapy [J].Asian Pac J Cancer P,2008,9(1):1-6.
  • 3Wang ZW,Li YW,Kong D,et al.Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway [J].Cancer Res,2009,69(6):2400-2407.
  • 4Zorzos HS,Lazaris AC,Korkolopoulour PA.Multidrug resistance proteins and topoisomerage Ⅱ alpha expression in colon cancer:association with metastatic potential [J].Pathology,2003,35(4):315-318.
  • 5Chaturvedi MM,Sung B,Yadav VR,et al.NF-kappa B addiction and its role in cancer:"one size does not fit all" [J].Oncogene,2011,30(14):1615-1630.
  • 6Devarajan E,Huang S.STAT3 as a central regulator of tumor metastases [J].Curr Mol Med,2009,9(5):626-633.
  • 7Larue L,Bellacosa A.Epithelial-mesenchymal transition in development and cancer:role of phosphatidylinositol 3' kinase/AKT pathways [J].Oncogene,2005,24(50):7443-7454.
  • 8Osaki M,Oshimura M,Ito H.PI3K-Akt pathway:Its functions and alterations in human cancer [J].Apoptosis,2004,9(6):667-676.
  • 9Tanno S,Mitsuuchi Y,Altomare DA.AKT activation up-regulates insulin-like grow factor I receptor expression and promotes invasiveness of human pancreatic cells [J].Cancer Res,2001,61(2):589-593.
  • 10Hannigan GE,Dedhar S.Protein kinase mediators of integrin signal transduction [J].J Mol Med,1997,75(1):35-44.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部